Page 273 - Pharmaceutics IV (02-06-01305)
P. 273

3/30/24

       Nebulizer formulation

    All nebulizers require a solution or suspension-based formulation,
    which places stringent demands on the solubility and stability of the
    drug in aqueous media
    For protein and peptide drugs, the stability of proteins and peptides
    upon shearing can pose additional limitation. Nebulization exerts high
    shear stress on these macromolecules, which can lead to their
    denaturation.
    The physical properties of drug solutions (e.g., ionic strength,
    viscosity, osmolarity, pH, and surface tension) may change with dosing
    and may affect the nebulization efficiency.

                                                                      Prof Alyaa Ramadan, ceutics, AU

53

     New types of nebulisers

       New generation of nebulizers: (A) AERx (Aradigm), (B) Respimat (Boehringer),
      (ultrasonic) generate an aerosol mechanically and reduce the shear forces on
      the drug
      (C) AeroDose (AeroGen Inc). vibrating mesh technologies (membrane)

            significant disadvantage of devices of this type is the high cost,
            which is an obstacle to theirPwrofidAelysapa Rreamadadauns, ceeutics, AU

54

                                                                                      27
   268   269   270   271   272   273   274   275   276   277   278